Australian Pharmaceutical Industries Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Australian Pharmaceutical Industries Ltd with three other
drug stores in Australasia:
Ebos Group Limited
of New Zealand
sales of 7.63 billion New Zealand Dollars [US$5.54 billion]
of which 94%
Sigma Healthcare Ltd
(4.44 billion Australian Dollars [US$3.54 billion]
of which 100%
was Healthcare), and
Medical Developments International Ltd
(18.36 million Australian Dollars [US$14.62 million]
of which 60%
During the year ended August of 2017, sales at
Australian Pharmaceutical Industries Ltd were A$4.07 billion (US$3.24 billion).
increase of 5.8%
versus 2016, when the company's sales were A$3.84 billion.
This was the fourth straight year of sales growth at Australian Pharmaceutical Industries Ltd.
Sales of Operating-Australia saw an increase
5.8% in 2017, from
A$3.79 billion to A$4.02 billion.
Not all segments of Australian Pharmaceutical Industries Ltd experienced an increase in sales in 2017:
sales of Operating-New Zealand fell 5.3% to A$50.65 million.
(However, this segment's sales were only a very small portion of the company's overall sales).